| Product Code: ETC9548394 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Antithrombotic Drugs Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Antithrombotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Antithrombotic Drugs Market - Industry Life Cycle |
3.4 Sweden Antithrombotic Drugs Market - Porter's Five Forces |
3.5 Sweden Antithrombotic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden Antithrombotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Sweden Antithrombotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Sweden Antithrombotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Sweden Antithrombotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Sweden Antithrombotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Antithrombotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Sweden |
4.2.2 Growing geriatric population in Sweden |
4.2.3 Advancements in antithrombotic drug research and development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of antithrombotic drugs |
4.3.2 Competition from alternative therapies such as non-pharmacological interventions |
4.3.3 Potential side effects and risks associated with antithrombotic drugs |
5 Sweden Antithrombotic Drugs Market Trends |
6 Sweden Antithrombotic Drugs Market, By Types |
6.1 Sweden Antithrombotic Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Antithrombotic Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Sweden Antithrombotic Drugs Market Revenues & Volume, By Apixaban, 2021- 2031F |
6.1.4 Sweden Antithrombotic Drugs Market Revenues & Volume, By Debigatran, 2021- 2031F |
6.1.5 Sweden Antithrombotic Drugs Market Revenues & Volume, By Edoxaban, 2021- 2031F |
6.1.6 Sweden Antithrombotic Drugs Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.1.7 Sweden Antithrombotic Drugs Market Revenues & Volume, By Heparin, 2021- 2031F |
6.1.8 Sweden Antithrombotic Drugs Market Revenues & Volume, By Rivaroxaban, 2021- 2031F |
6.2 Sweden Antithrombotic Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Sweden Antithrombotic Drugs Market Revenues & Volume, By Thrombolytic Drugs, 2021- 2031F |
6.2.3 Sweden Antithrombotic Drugs Market Revenues & Volume, By Anti-Platelet Drugs, 2021- 2031F |
6.2.4 Sweden Antithrombotic Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.2.5 Sweden Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sweden Antithrombotic Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Sweden Antithrombotic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.3.3 Sweden Antithrombotic Drugs Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Sweden Antithrombotic Drugs Market Revenues & Volume, By Deep vein thrombosis (DVT), 2021- 2031F |
6.3.5 Sweden Antithrombotic Drugs Market Revenues & Volume, By Pulmonary Embolism (PE), 2021- 2031F |
6.3.6 Sweden Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sweden Antithrombotic Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Sweden Antithrombotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Sweden Antithrombotic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Sweden Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Sweden Antithrombotic Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Sweden Antithrombotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Sweden Antithrombotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Sweden Antithrombotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Sweden Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Sweden Antithrombotic Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Sweden Antithrombotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Sweden Antithrombotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Sweden Antithrombotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Sweden Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Antithrombotic Drugs Market Import-Export Trade Statistics |
7.1 Sweden Antithrombotic Drugs Market Export to Major Countries |
7.2 Sweden Antithrombotic Drugs Market Imports from Major Countries |
8 Sweden Antithrombotic Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to antithrombotic drug therapy |
8.2 Number of clinical trials for new antithrombotic drugs in Sweden |
8.3 Rate of adoption of novel antithrombotic drug formulations |
8.4 Average age of patients prescribed antithrombotic drugs |
8.5 Frequency of adverse events reported for antithrombotic drugs |
9 Sweden Antithrombotic Drugs Market - Opportunity Assessment |
9.1 Sweden Antithrombotic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden Antithrombotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Sweden Antithrombotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Sweden Antithrombotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Sweden Antithrombotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Sweden Antithrombotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Antithrombotic Drugs Market - Competitive Landscape |
10.1 Sweden Antithrombotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Sweden Antithrombotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here